Esomeprazole Magnesium Granule, Delayed Release
Product Images NDC 59651-803

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 59651-803). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig (Esomeprazole Fig1)

A line graph showing the percent maintained over six months for four groups: NEXIUM 40 mg, NEXIUM 20 mg, NEXIUM 10 mg, and placebo. The x-axis represents months, and the y-axis represents percent maintained. The graph compares the performance of different NEXIUM dosages versus placebo over time.*

FDA Label Image

Fig (Esomeprazole Fig2)

A line graph showing percent maintained over months (1S to 6S) for four groups: NEXIUM 40 mg, NEXIUM 20 mg, NEXIUM 10 mg, and Placebo, each with different sample sizes (n=82 or n=77). The y-axis represents percent maintained from 0 to 100, and the x-axis represents time in months. The graph compares the performance of different NEXIUM dosages and placebo over a six-month period.*

FDA Label Image

Fig (Esomeprazole Fig3)

A line graph showing the percent of patients symptom-free over 28 diary days for three groups: Nexium 40 mg, Nexium 20 mg, and placebo. The y-axis represents the percent of patients symptom-free, and the x-axis represents diary days from 0 to 28. Data trends for each group are indicated by distinct lines and markers.*

FDA Label Image

Fig (Esomeprazole Fig4)

A line graph showing the percentage of patients symptom-free over a 28-day diary period. It compares three groups: Nexium 40 mg, Nexium 20 mg, and placebo. The y-axis represents the percent of patients symptom-free, while the x-axis represents diary days from 0 to 28.*

FDA Label Image

Fig (Esomeprazole Fig5)

The image shows the packaging label for Esomeprazole Magnesium For Delayed-Release Oral Suspension 10 mg by Aurobindo Pharma Limited. It features dosing information, medication guide instructions, NDC 59651-803-03, and branding with the Aurobindo logo. The label highlights the granule form of the 10 mg strength delayed-release oral suspension.*

FDA Label Image

Fig (Esomeprazole Fig6)

Label for Esomeprazole Magnesium 10 mg delayed-release oral suspension granules by Aurobindo Pharma Limited. The label shows the product name, dosage strength, Rx only designation, and instructions to dispense the Medication Guide separately. It indicates the package contains 30 single-dose packets. The label also includes storage information, usage instructions, manufacturer details, and barcodes.*

FDA Label Image

Str (Esomeprazole Str)

Chemical structure diagram of esomeprazole magnesium trihydrate, showing the molecular arrangement of esomeprazole molecules chelated with magnesium ions and associated water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.